Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and in vitro cellular studies

PurposeComplicated intra-abdominal infection (cIAI) management involves administering antibiotics that destroy the cell wall and the genesis of bacterial lipopolysaccharide (LPS). During the infectious state, the expression of transferrin receptors upregulates on the intestinal epithelial cells, which are considered the site of infection. In the present research, transferrin decorated poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) encapsulated moxifloxacin (MOX) were developed for possible targeting of the receptors in the colon.SignificanceThis study will explore more about the incorporation of transferrin as effective coating material in targeted drug delivery.MethodsNanoparticles were prepared using nano-emulsification and surface modification with transferrin was done by layer-by-layer methodology and evaluated by powder X-ray diffraction (PXRD), differential scanning calorimeter (DSC), FTIR, SEM, antibacterial activity, and cellular uptake studies.ResultsThe formulated NPs exhibit a size of approximate to 170 nm, PDI approximate to 0.25, zeta potential approximate to-4.0 mV, drug loading approximate to 6.8%, and entrapment efficiency of 82%. Transferrin-decorated NPs exhibit tailored release for almost 12 h and in vitro antibacterial activity for 14 h. The cellular uptake studies were done on a RAW264.7 cell line for better determination of transferrin uptake of fabricated NPs.ConclusionThe above study circumvents around the preparation of transferrin decorated PLGA encumbered MOX NPs intended for cIAI-induced sepsis. PLGA NPs provide tailored release of MOX with primary burst and followed by sustained release. These observations confines with antibacterial activity studies. The prepared transferrin-coated NPs were stable and effectively uptaken by RAW264.7 cells. However, future studies include the preclinical investigation of these NPs in sepsis-induced murine models.

Automated summary

This study investigates the incorporation of transferrin as an effective coating material for targeted drug delivery. Nanoparticles were prepared and transferrin was surface modified using layer-by-layer methodology. Their properties, drug release, antibacterial activity, and cellular uptake were evaluated.